Long-Term PPI Use or Fundoplication for GERD Treatment

Published Online: Friday, May 30, 2014
Follow Pharmacy_Times:
In this podcast, experts discuss the pros and cons of long-term proton pump inhibitor use and surgical fundoplication in patients with gastroesophageal reflux disease.

To listen to the podcast, click here.
Related Articles
Since patients with Barrett’s esophagus seem to progress to cancerous stages faster than others, health care professionals might perceive that controlling acid reflux would prevent the transition.
Gastroesophageal reflux disease and atrial fibrillation are 2 of the most significant health concerns in the United States, and researchers suspect a link between them.
A recent study suggests that co-administering the muscle relaxant, baclofen, with the proton pump inhibitor (PPI), omeprazole, may be more effective than PPI monotherapy in reducing heartburn and regurgitation in patients with gastroesophageal reflux disease (GERD).
A systematic review recently reported that antidepressants were beneficial for GERD patients – curbing esophageal sensation and reducing functional chest pain.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$